Latest News in the pharma Industry

Research & Development

EMA accepts for review the Marketing Authorisation Application for sarilumab

EMA accepts for review the Marketing Authorisation Application for sarilumab

1 Aug 2016

Sarilumab is an investigational human monoclonal antibody directed against the IL-6 receptor that is intended for the treatment of adult patients with moderately to severely active rheumatoid arthritis.

Read more 
Sunovion submits NDA for SUN-101/eFlow to FDA for the treatment of patients with COPD

Sunovion submits NDA for SUN-101/eFlow to FDA for the treatment of patients with COPD

31 Jul 2016

If approved, SUN-101/eFlow will be the first nebulized long-acting muscarinic antagonist (LAMA) for the long-term, maintenance treatment of airflow obstruction in patients with COPD.

Read more 
NIH-led researchers develop software that could facilitate drug development

NIH-led researchers develop software that could facilitate drug development

29 Jul 2016

AptaTRACE is the first algorithm that uses the full scope of sequencing data from a large number of selection rounds to capture sequence and structure features of aptamers that bind to the target.

Read more 
Shire’s SHP626 (volixibat) receives FDA fast track designation

Shire’s SHP626 (volixibat) receives FDA fast track designation

29 Jul 2016

Designation is for an investigational treatment of adults who have nonalcoholic steatohepatitis (NASH) with liver fibrosis.

Read more 
New studies suggest relationship between tau pathology and progression of Alzheimer's disease

New studies suggest relationship between tau pathology and progression of Alzheimer's disease

28 Jul 2016

Analysis shows a correlation between tau tangles and cognitive decline in patients living with Alzheimer's disease.

Read more 
Axol Bioscience and Metrion Biosciences announce research collaboration

Axol Bioscience and Metrion Biosciences announce research collaboration

26 Jul 2016

The human cell culture specialists join experts in ion channel research to study human iPSC-derived cardiomyocytes for drug discovery applications.

Read more 
BMS announces new research collaboration with Janssen in immuno-oncology

BMS announces new research collaboration with Janssen in immuno-oncology

26 Jul 2016

The research will evaluate Opdivo and live attenuated double–deleted Listerial monocytogenes cancer immunotherapy

Read more 
Celgene decides against pursuing new indication for its Revlimid

Celgene decides against pursuing new indication for its Revlimid

26 Jul 2016

Data from a Phase III study indicate overall survival showed no benefit of Revlimid.

Read more 
Alzheon presents positive results of ALZ-801 clinical studies

Alzheon presents positive results of ALZ-801 clinical studies

25 Jul 2016

Pharmacokinetic and safety data from Phase Ib studies with ALZ-801, an optimized prodrug of tramiprosate, presented at the Alzheimer's Association International Conference.

Read more 
Allergan receives Positive Opinion For Truberzi for treatment of IBS-D in adults

Allergan receives Positive Opinion For Truberzi for treatment of IBS-D in adults

25 Jul 2016

Significant step towards bringing the only licensed prescription medication for IBS-D to patients in 28 countries of the EU.

Read more 
AbbVie and BMS announce oncology clinical collaboration to evaluate the combination of Rova-T plus Opdivo and Opdivo + Yervoy regimen

AbbVie and BMS announce oncology clinical collaboration to evaluate the combination of Rova-T plus Opdivo and Opdivo + Yervoy regimen

25 Jul 2016

Collaboration will explore the safety and potential enhanced efficacy of combining checkpoint inhibitors with a cancer stem cell-targeting antibody drug conjugate in SCLC.

Read more 
N-of-One Secures $7 Million in Series B financing

N-of-One Secures $7 Million in Series B financing

24 Jul 2016

The financing will be used to expand the company's leading precision medicine decision support solutions in oncology.

Read more